Central Admixture Pharmacy Services, Inc.

CLOSEOUT LETTER Central Admixture Pharmacy Services, Inc. MARCS-CMS 498479 — June 17, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Certified Email Product: Drugs Recipient: Recipient Name Thomas J. Wilverding Recipient Title President Central Admixture Pharmacy Services, Inc. 6580 Snowdrift Road Suite 100 Allentown , PA 18106-9331 United States Issuing Office: Division of Pharmaceutical Quality Operations I United States (973) 331-4900 Dear Mr. Wilverding: We are enclosing a copy of the Establishment Inspection Report (EIR) for the inspection conducted at your facility, Central Admixture Pharmacy Services, Inc., located at 6580 Snowdrift Road, Suite 100, Allentown, PA 18106-9331, from July 30, 2018, to August 22, 2018, by the U.S. Food and Drug Administration (FDA). We are also releasing a copy of the Establishment Inspection Report (EIR)s for the inspections conducted August 29, 2016, to September 19, 2016, February 3, 2015 to February 11, 2015, and June 4, 2014, to June 11, 2014. When the Agency concludes that an inspection is “closed” under 21 C.F.R. 20.64(d)(3), it will release a copy of the EIR to the inspected establishment. The Agency continually works to make its regulatory process and activities more transparent for regulated industry. Releasing this EIR to you is part of this effort. The copy being provided to you comprises the narrative portion of the report; it may reflect redactions made by the Agency in accordance with the Freedom of Information Act (FOIA) and 21 C.F.R. Part 20. This, however, does not preclude you from requesting and possibly obtaining any additional information under FOIA. If there is any question about the released information, please contact Yvette Johnson, Compliance Officer at Yvette.Johnson@fda.hhs.gov . Sincerely, /S/ Stephanie Durso, Compliance Branch Director Office of Pharmacy Quality Operations, Division I Content current as of: 06/23/2020 Regulated Product(s) Drugs